TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancerHERMANS, Karin G; VAN MARION, Ronald; VAN DEKKEN, Herman et al.Cancer research (Baltimore). 2006, Vol 66, Num 22, pp 10658-10663, issn 0008-5472, 6 p.Article

The human PC346 xenograft and cell line panel : A model system for prostate cancer progressionMARQUES, Rute B; VAN WEERDEN, Wytske M; ERKENS-SCHULZE, Sigrun et al.European urology. 2006, Vol 49, Num 2, pp 245-257, issn 0302-2838, 13 p.Article

Activin A Stimulates AKR1C3 Expression and Growth in Human Prostate CancerHOFLAND, Johannes; VAN WEERDEN, Wytske M; STEENBERGEN, Jacobie et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 12, pp 5726-5734, issn 0013-7227, 9 p.Article

Androgen receptor modifications in prostate cancer cells upon long-term androgen ablation and antiandrogen treatmentMARQUES, Rute B; ERKENS-SCHULZE, Sigrun; DE RIDDER, Corrina M et al.International journal of cancer. 2005, Vol 117, Num 2, pp 221-229, issn 0020-7136, 9 p.Article

Different profiles of neuroendocrine cell differentiation evolve in the PC-310 human prostate cancer model during long-term androgen deprivationJONGSMA, Johan; OOMEN, Monique H; NOORDZIJ, Marinus A et al.The Prostate. 2002, Vol 50, Num 4, pp 203-215, issn 0270-4137Article